Melanotan I Powder Hormone Tanning Skin Peptides API For Sale
Alias: Melanotan-1, Melanotan I, Afamelanotide, Melanotan, CUV1647, EPT1647, NDP-MSH, [Nle4, D-Phe7]α -MSH
CAS: 75921-69-6
Séquence: Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
Formule moléculaire: C78H111N21O19
Masse moléculaire: 1646.845
Origine: Chine
Apparence: White Crystalline Powder
Fabrication personnalisée: Personnalisé
Convient à: Âgé, Adulte
Pureté: >98%
Autre nom: Mt1, Melanotan I, Mt I
Heavy Metals: <=10ppm
Lead: <=3ppm
Cadmium: <=1ppm
Yeast & Mold: <=100cfu/G
Arsenic: <=1ppm
Mercury: <=0.1ppm
Total Plate Count: <=1000cfu/G
Marque déposée: WuMeiTech
What is Melanotan I and the use?
Afamelanotide (melanotan I, CUV1647; brand name Scenesse) is a synthetic peptide and analogue of α-melanocyte stimulating hormone used to prevent skin damage from the sun in people with erythropoietic protoporphyria in Europe since January 2015. It is administered as an implant that is placed under the skin; the implant lasts for two months.
It is under development in other skin disorders in several jurisdictions. It causes skin to turn darker by causing the skin to make more melanin.
It was discovered at University of Arizona and initially developed there as a sunless tanning agent; the Australian company Clinuvel conducted further clinical trials in that and other indications, and brought the drug to market.
